A novel lotion formulation of 20% oxybutynin hydrochloride for the treatment of primary palmar hyperhidrosis: A randomized, placebo-controlled, double-blind, phase III study.

Fujimoto, Tomoko; Terahara, Takaaki; Okawa, Koji; Inakura, Hiroshi; Hirayama, Yuta; Yokozeki, Hiroo

Fujimoto, Tomoko; Terahara, Takaaki; Okawa, Koji; Inakura, Hiroshi; Hirayama, Yuta; Yokozeki, Hiroo.

Afiliação

Fujimoto T; Ikebukuro Nishiguchi Fukurou Dermatology Clinic, Tokyo, Japan.
Terahara T; R&D Division, Hisamitsu Pharmaceutical Co, Inc, Tokyo, Japan.
Okawa K; R&D Division, Hisamitsu Pharmaceutical Co, Inc, Tokyo, Japan.
Inakura H; R&D Division, Hisamitsu Pharmaceutical Co, Inc, Tokyo, Japan.
Hirayama Y; R&D Division, Hisamitsu Pharmaceutical Co, Inc, Tokyo, Japan. Electronic address: Yuta_Hirayama@hisamitsu.co.jp.
Yokozeki H; Department of Dermatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

J Am Acad Dermatol ; 89(1): 62-69, 2023 07.

Article em En | MEDLINE | ID: mdl-36990320

Assuntos

Hiperidrose; Ácidos Mandélicos; Humanos; Resultado do Tratamento; Ácidos Mandélicos/efeitos adversos; Hiperidrose/diagnóstico; Hiperidrose/tratamento farmacológico; Suor; Método Duplo-Cego

Palavras-chave

Hyperhidrosis Disease Severity Scale (HDSS); oxybutynin hydrochloride; perspiration meter; primary palmar hyperhidrosis; sweat volume; ventilated capsule method

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hiperidrose / Ácidos Mandélicos Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google